Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballantyne

Showing results (671-680 of 2,426) with videos related to

Pageof 243
Sort By:
Acta Oto-Laryngologica|July 1, 2004
Short-term study of the effect of speech coding strategy on the auditory performance of pre- and post-lingually deafened adults implanted with the Clarion CIIR Filipo, P Mancini, D Ballantyne, et al.
RNA (New York, N.Y.)|March 1, 1995
Poly (A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early developmentS Ballantyne, A Bilger, J Astrom, et al.
Brain and Language|May 22, 2009
Spectral vs. temporal auditory processing in specific language impairment: a developmental ERP studyR Ceponiene, A Cummings, B Wulfeck, et al.
Forensic Science International|June 4, 2017
DNA decontamination of fingerprint brushesBianca Szkuta, Roland A H van Oorschot, Kaye N Ballantyne
ANS. Advances in Nursing Science|August 1, 2020
Visual Elicitation: Methods for Enhancing the Quality and Depth of Interview Data in Applied Qualitative Health ResearchElizabeth R Orr, Marilyn Ballantyne, Andrea Gonzalez, et al.
Archives of Toxicology|November 20, 1975
The comparative ophthalmic toxicology of 1-chloroacetophenone (CN) and dibenz(b.f)-1:4-oxazepine(CR)B Ballantyne, M F Gazzard, D W Swanston, et al.
Kidney International. Supplement|November 1, 1990
Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin IIM Steinhausen, D Ballantyne, M Fretschner, et al.
The American Journal of Cardiology|March 1, 2000
Strategies for implementing lipid-lowering therapy: pharmacy-based approachK K Birtcher, C Bowden, C M Ballantyne, et al.
Current Cardiovascular Risk Reports|September 1, 2020
The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol GuidelinesAnandita Agarwala, Jing Liu, Christie M Ballantyne, et al.
Journal of Primary Health Care|October 24, 2025
Using AI scribes in New Zealand primary care consultations: an exploratory surveyAngela Ballantyne, Rochelle Style, Maria Stubbe, et al.
Pageof 243

Showing results (671-680 of 2,426) with videos related to

Sort By:
Pageof 243
Acta Oto-Laryngologica|July 1, 2004
Short-term study of the effect of speech coding strategy on the auditory performance of pre- and post-lingually deafened adults implanted with the Clarion CIIR Filipo, P Mancini, D Ballantyne, et al.
RNA (New York, N.Y.)|March 1, 1995
Poly (A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early developmentS Ballantyne, A Bilger, J Astrom, et al.
Brain and Language|May 22, 2009
Spectral vs. temporal auditory processing in specific language impairment: a developmental ERP studyR Ceponiene, A Cummings, B Wulfeck, et al.
Forensic Science International|June 4, 2017
DNA decontamination of fingerprint brushesBianca Szkuta, Roland A H van Oorschot, Kaye N Ballantyne
ANS. Advances in Nursing Science|August 1, 2020
Visual Elicitation: Methods for Enhancing the Quality and Depth of Interview Data in Applied Qualitative Health ResearchElizabeth R Orr, Marilyn Ballantyne, Andrea Gonzalez, et al.
Archives of Toxicology|November 20, 1975
The comparative ophthalmic toxicology of 1-chloroacetophenone (CN) and dibenz(b.f)-1:4-oxazepine(CR)B Ballantyne, M F Gazzard, D W Swanston, et al.
Kidney International. Supplement|November 1, 1990
Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin IIM Steinhausen, D Ballantyne, M Fretschner, et al.
The American Journal of Cardiology|March 1, 2000
Strategies for implementing lipid-lowering therapy: pharmacy-based approachK K Birtcher, C Bowden, C M Ballantyne, et al.
Current Cardiovascular Risk Reports|September 1, 2020
The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol GuidelinesAnandita Agarwala, Jing Liu, Christie M Ballantyne, et al.
Journal of Primary Health Care|October 24, 2025
Using AI scribes in New Zealand primary care consultations: an exploratory surveyAngela Ballantyne, Rochelle Style, Maria Stubbe, et al.
Pageof 243